Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma
Kathryn M. Field, Madeleine T. King, John Simes, David Espinoza, Elizabeth H. Barnes, Kate Sawkins, Mark A. Rosenthal, Lawrence Cher, Elizabeth Hovey, Helen Wheeler, Anna K. Nowak
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma'. Together they form a unique fingerprint.